Colorado spinout Mita has been acquired for an undisclosed sum after developing an orthopaedic device that reduces complications during hip distraction.
Mita, a US-based orthopaedic device spinout from University of Colorado, has been acquired by medical technology developer Stryker for an undisclosed sum.
Founded in 2009, Mita has developed an orthopaedic device for hip distraction, a procedure used to treat arthritis in young people and a condition called avascular necrosis, where bone tissue is killed due to a lack of blood supply. Mita’s device does not feature a perineal post, an element linked to groin-related complications.
Stryker officially launched its own post-free hip distraction implant in March 2018, though it did not explicitly mention Mita at the time.
Omer Mei-Dan, an orthopaedic surgeon in Colorado’s School of Medicine, formulated the design alongside Robin Shandas, chair professor for bioengineering in the College of Engineering and Applied Science of Anschutz Medical Campus at University of Colorado Denver.
The pair was assisted by Jacob Segil, an instructor on University of Colorado Boulder’s Engineering Plus degree program, and Brett Schumer, an orthopaedic device consultant. Mita does not appear to have disclosed funding previously.
Shandas said: “The fact that our Bioengineering Department is located on the CU Anschutz Medical Campus really facilitates such multi-disciplinary interactions.
“We built a technical team very quickly to execute on Dr. Mei-Dan’s vision to help his patients, while at the same time building the startup company to carry the idea into commercial reality.”
